Research Papers
This database includes peer-reviewed publications authored by TB Alliance staff. Use the tags on the left to filter by subject, or search for a particular author or term using the search bar.
Tag: Childhood TB
Displaying 17 papers
Stable compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field
Publication: International Journal of Tuberculosis and Lung Disease
3/2023
Extemporaneously compounded liquid formulations of clofazimine
Publication: International Journal of Tuberculosis and Lung Disease
2/2023
Sugar and sugar-free liquid formulations of delamanid for patients with rifampicin-resistant TB
Publication: International Journal of Tuberculosis and Lung Disease
1/2023
Stable sugar and sugar-free suspensions of pretomanid
Publication: International Journal of Tuberculosis and Lung Disease
12/2022
The impact of HIV and antiretroviral therapy on TB risk in children: A systematic review and meta-analysis
Publication: Thorax Online, 23 Jan. 2017. Web. 31 Jan. 2017.
1/2017
Global burden of drug-resistant tuberculosis in children: a mathematical modelling study
Publication: Peter J Dodd, Charalambos Sismanidis, James A Seddon. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. The Lancet Infectious Diseases , Volume 0 , Issue 0
6/2016
The pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in infants dosed at revised WHO-recommended treatment guidelines
Publication: Bekker A, Schaaf HS, Murray S, et. al. The pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in infants... Antimicrob Agents Chemother. 2016 Jan 25. pii: AAC.02600-15. doi: 10.1128/aac.02600-15.
1/2016
The procurement landscape of pediatric tuberculosis treatment: a Global Drug Facility perspective
Publication: Scott C, Gardiner E, de Lucia A. The procurement landscape of pediatric tuberculosis treatment: a Global Drug Facility perspective. Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:17-22. doi: 10.5588/ijtld.15.0478.
12/2015
Accelerating clinical drug development for children with tuberculosis
Publication: Murray S, McKenna L, Pelfrene E, Botgros R. Accelerating clinical drug development for children with tuberculosis. Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:69-74. doi: 10.5588/ijtld.15.0616.
12/2015
From availability to uptake: planning for the introduction of new, child-friendly anti-tuberculosis formulations
Publication: Malhotra S, Ursu I, Ghoneim R, et. al. From availability to uptake: planning for the introduction of new, child-friendly anti-tuberculosis formulations. Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:32-8. doi: 10.5588/ijtld.15.0482.
12/2015
Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations
Publication: Taneja R, Garcia-Prats AJ, Furin J, Maheshwari HK. Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations. Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:61-8. doi: 10.5588/ijtld.15.0435.
12/2015
Pediatric tuberculosis drug market: an insider perspective on challenges and solutions
Publication: Usherenko I, Basu Roy U, Mazlish S, et. al. Pediatric tuberculosis drug market: an insider perspective on challenges and solutions. Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:23-31. doi: 10.5588/ijtld.15.0479.
12/2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement
Publication: Nachman S, Ahmed A, Amanullah, et. al. Towards early inclusion of children in tuberculosis drugs trials: a consensus statement. Lancet Infect Dis. 2015 Jun;15(6):711-20. doi: 10.1016/S1473-3099(15)00007-9.
5/2015
Burden of childhood tuberculosis in 22 high-burden countries, a mathematical modelling study
Publication: Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014 Aug;2(8):e453-9. doi: 10.1016/S2214-109X(14)70245-1.
7/2014
Requirements for the clinical evaluation of new anti-tuberculosis agents in children
Publication: Donald PR, Ahmed A, Burman WJ, et. al. Requirements for the clinical evaluation of new anti-tuberculosis agents in children. Int J Tuberc Lung Dis. 2013 Jun;17(6):794-9. doi: 10.5588/ijtld.12.0567.
6/2013
New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future
Publication: Lienhardt C, Raviglione M, Spigelman M, et. al. New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future. J Infect Dis. 2012 May 15;205 Suppl 2:S241-9. doi: 10.1093/infdis/jis034.
3/2012
Global tuberculosis drug development pipeline: the need and the reality
Publication: Ma Z, Lienhardt C, McIlleron H, Nunn AJ, Wang X. Global tuberculosis drug development pipeline: the need and the reality. Lancet. 2010 Jun 12;375(9731):2100-9. doi: 10.1016/S0140-6736(10)60359-9.
5/2010